Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Family planning and multiple sclerosis - Part 1: Patient perspectives on treatment choices in Sweden.
Non-Syndromic Tumefactive Demyelinating Lesions in the Pediatric Population: Four Case Reports and Review of the Literature.
[Ureaplasma infections in the immunocompromised patient].
Recombinant rat heat shock protein 70 (rrHSP70) may promote remyelination by regulating microglia/macrophages and oligodendrocytes in a toxin-induced demyelination animal model.
A microRNA atlas of CD4+ T cell subsets in experimental autoimmune encephalomyelitis identifies regulators of disease pathogenesis.
Neurofascin Antibodies in a Large Cohort of Inflammatory Neuropathies from India.
Eculizumab treatment in the salvage therapy of MOGAD: a case report.
An Overview of 1,2,4-Triazole-5-Thiol and 3-Thione Derivatives as Promising Scaffolds for Anti-Neuroinflammatory Drug Discovery.
Emergency department use before multiple sclerosis: Presenting complaints and discharge diagnoses.
Pediatric Meningitis-Retention Syndrome With Anti-MOG Antibodies: A Report of Two Cases.
Fifteen-Year Longitudinal Changes in Peripapillary Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis.
A Robust Dual-Stage Learning-Based Pipeline for Multiclass Segmentation of Multiple Sclerosis Lesions in MRI.
Anti-CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non-Active Multiple Sclerosis.
Intractable hiccups as a brainstem red flag: demyelinating disorders with emphasis on neuromyelitis optica spectrum disorder and area postrema syndrome.
Neuroimmunological overlap syndromes in optic neuritis, myelitis, and connective tissue diseases.
Characteristics of glioma in L-2-Hydroxyglutaric Aciduria: a case report and literature review.
Impact of age at onset on relapse-associated and relapse-independent disability accrual trajectories in multiple sclerosis.
The gut microbiome plays a modifiable role in MS progression-No.
Patient voices - Resources aside I would like my family to be screened for MS - YES.
Dose-Dependent Effects of Minocycline on Facial Nerve Regeneration: A Microscopic and Molecular Study.
Determinants of relapse risk under disease-modifying therapies in multiple sclerosis: an Andersen-Gill Cox regression analysis.
Free Epstein-Barr virus-induced gene 3 functions as an autonomous immunosuppressive cytokine to maintain immune tolerance.
Protective effect of Glycyrrhizin on cuprizone-induced model of multiple sclerosis in male C57BL/6 mice.
Ultrastructural neuroprotection by intrathecal interleukin-6 antagonism in a rat model of permanent focal cerebral ischemia.
LMNB1 reduction is a potential therapeutic strategy in a mouse model of Autosomal Dominant Leukodystrophy.
Pages
« first
‹ previous
…
926
927
928
929
930
931
932
933
934
…
next ›
last »